Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05391555
Other study ID # 21-34917
Secondary ID
Status Recruiting
Phase Phase 2/Phase 3
First received
Last updated
Start date October 1, 2022
Est. completion date August 31, 2023

Study information

Verified date October 2022
Source University of California, San Francisco
Contact Rachel Eshima McKay, MD
Phone 415-502-1715
Email rachel.eshima@ucsf.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will establish the relationship between magnitude of opioid exposure and a pupillary measure referred to as PUAL (pupillary unrest in ambient light), in subjects aged 40-60. Previous investigation demonstrated that loss of PUAL was a sensitive, discriminative indicator of opioid toxicity and respiratory depression among subjects aged 20-40 years old. Population data indicate that pupil size and PUAL decline slightly with age. The investigators will explore whether PUAL proves to be a sensitive indicator of opioid exposure and respiratory depression in this older group.


Description:

Healthy volunteer subjects aged 40-60 will receive a standardized weight-based 10-minute remifentanil infusion protocol to achieve a peak estimated remifentanil effect site concentration of approximately 6 ng/mL. Pupillary measures will be taken at baseline and regular time intervals during and after the infusion, over a period of 35 minutes.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date August 31, 2023
Est. primary completion date August 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 60 Years
Eligibility Inclusion Criteria: - Healthy, BMI < 35 kg/m2 Exclusion Criteria: - current or recent opioid use - opioid or other substance use disorder - known or suspected OSA or sleep disordered breathing - ischemic heart disease, heart failure or symptomatic arrhythmia history - ocular disease or previous eye surgery - active use of alpha adrenergic blockers, anticholinergic medications, - active use of antidepressant or mood stabilizing medications - active use of phosphodiesterase inhibitors - use of stimulant or appetite suppressant medications - active use of antihypertensive or antiarrhythmic medications - use of topical eye medications.

Study Design


Intervention

Drug:
Remifentanil Hydrochloride
Infusion of 0.2 µg/k/m for 5 minutes, the 0.3 µg/k/m for 5 minutes. Pupillary measurements will be taken at baseline and every 2.5 minutes during the 10-minute infusion and 25-minute recovery period.
Device:
Pupillometry measurement
The pupil will be examined with the pupillometer at regular intervals, before during and after the opioid infusion

Locations

Country Name City State
United States University of California San Francisco San Francisco California

Sponsors (1)

Lead Sponsor Collaborator
University of California, San Francisco

Country where clinical trial is conducted

United States, 

References & Publications (3)

McKay RE, Kohn MA, Larson MD. Pupillary unrest, opioid intensity, and the impact of environmental stimulation on respiratory depression. J Clin Monit Comput. 2022 Apr;36(2):473-482. doi: 10.1007/s10877-021-00675-3. Epub 2021 Mar 2. — View Citation

McKay RE, Larson MD. Detection of opioid effect with pupillometry. Auton Neurosci. 2021 Nov;235:102869. doi: 10.1016/j.autneu.2021.102869. Epub 2021 Aug 18. — View Citation

McKay RE, Neice AE, Larson MD. Pupillary Unrest in Ambient Light and Prediction of Opioid Responsiveness: Case Report on Its Utility in the Management of 2 Patients With Challenging Acute Pain Conditions. A A Pract. 2018 May 15;10(10):279-282. doi: 10.1213/XAA.0000000000000710. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Area Under the Time Concentration Curve (AUC 0-35 minutes) PUAL measured by pupillometer. Baseline, and every 2.5 minutes during 10-minute infusion and 25-minute recovery
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03441282 - Precision Medicine in Anesthesia: Genetic Component in Opioid-induced Respiratory Depression
Completed NCT02907255 - Vital Sign Monitoring With Continuous Pulse Oximetry and Wireless Clinician Notification After Surgery N/A
Completed NCT00544947 - Observation of Respiration Following Regional Anaesthesia With Intrathecal Opioids for Caesarean Section N/A
Completed NCT02987985 - Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy Phase 3
Completed NCT02481570 - Anesthetic Optimization in Scoliosis Surgery N/A
Completed NCT06083272 - VitalThings Guardian Contactless Monitoring
Not yet recruiting NCT06064409 - Optimal Timing and Failure Prediction of High Flow Nasal Cannula Oxygen Therapy in Emergency Department: Prospective Observational Single Center Study
Completed NCT00345384 - Dexmedetomidine for the Control of Post-Operative Pain in Thoracotomy Patients Phase 1/Phase 2
Recruiting NCT04046068 - Multimodal Perioperative Pain Management: ComfortSafe Program
Recruiting NCT02819661 - Respiratory Depression in Women With BMI≥30 Underwent Spinal Anesthesia With Intrathecal Morphine in Elective C-section N/A
Active, not recruiting NCT04011163 - Vital Signs-Integrated Patient-Assisted Intravenous Opioid Analgesia for Post Surgical Pain Phase 2/Phase 3
Active, not recruiting NCT06374589 - Closed-Loop O2 Use During High Flow Oxygen Treatment Of Critical Care Adult Patients (CLOUDHFOT) N/A
Terminated NCT02760927 - Assessment of a Oral Endotracheal Tube Fastener on Patients Intubated With Oral Endotracheal Tubes N/A
Completed NCT01869582 - Safer Births - Reducing Perinatal Mortality N/A
Completed NCT00875134 - Testing of the Apnea Prevention Device Phase 1/Phase 2
Not yet recruiting NCT06137638 - ENA-001 for Post Operative Respiratory Depression (PORD) Phase 2
Completed NCT01843933 - Detecting Post-Operative Respiratory Depression in Children N/A
Completed NCT00696137 - Long-term Extension Study of BEMA™ Fentanyl Phase 3
Completed NCT04017702 - Detection of Postoperative Respiratory Depression in High Risk Patients Utilizing Minute Ventilation Monitoring
Withdrawn NCT04495452 - Precision Medicine in Anesthesia